Sernova Corp. (OTCMKTS:SEOVF) Short Interest Update

Sernova Corp. (OTCMKTS:SEOVF) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 7,400 shares, a drop of 35.1% from the May 31st total of 11,400 shares. Based on an average trading volume of 55,300 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

Separately, Raymond James started coverage on shares of Sernova in a report on Thursday, April 4th. They set a “market perform” rating and a $1.50 price objective on the stock.

Sernova Stock Down 3.0 %

Sernova stock traded down $0.01 during mid-day trading on Friday, reaching $0.24. The company’s stock had a trading volume of 4,255 shares, compared to its average volume of 19,590. The company has a market capitalization of $73.60 million, a price-to-earnings ratio of -2.69 and a beta of 1.20. Sernova has a 12 month low of $0.20 and a 12 month high of $0.81. The business’s 50 day simple moving average is $0.26 and its 200 day simple moving average is $0.38. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.20 and a current ratio of 0.62.

Sernova (OTCMKTS:SEOVF) last released its earnings results on Friday, June 14th. The company reported ($0.02) earnings per share for the quarter.

About Sernova

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.